Stanley Leon HAZEN

Person

Pepper Pike, OH, US

People

Patents Grantslast 30 patents

Information Patent Grant
Detection of glucuronidated and 3-bromotyrosine
- Patent number 12,092,648
- Issue date Sep 17, 2024
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- G01 - MEASURING TESTING
Information Patent Grant
Trimethylamine compounds as risk predictors of cardiovascular disease
- Patent number 12,055,535
- Issue date Aug 6, 2024
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- H01 - BASIC ELECTRIC ELEMENTS
Information Patent Grant
Treating and preventing disease with TMA and TMAO lowering agents
- Patent number 11,911,399
- Issue date Feb 27, 2024
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TMA-formation inhibitor treatment for elevated TMA-containing compo...
- Patent number 11,835,503
- Issue date Dec 5, 2023
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NMR quantification of TMAO
- Patent number 11,782,002
- Issue date Oct 10, 2023
- LipoScience, Inc.
- James D. Otvos
- G01 - MEASURING TESTING
Information Patent Grant
Treating disease and promoting weight loss by inhibiting the TMA/FM...
- Patent number 11,771,659
- Issue date Oct 3, 2023
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for inhibiting conversion of choline to trimethylamine (TMA)
- Patent number 11,331,280
- Issue date May 17, 2022
- The Procter & Gamble Company
- Stanley Leon Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for inhibiting conversion of choline to trimethylamine (TMA)
- Patent number 11,246,844
- Issue date Feb 15, 2022
- The Procter & Gamble Company
- Stanley Leon Hazen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Detection of glucuronidated and 3-bromotyrosine
- Patent number 11,249,091
- Issue date Feb 15, 2022
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- G01 - MEASURING TESTING
Information Patent Grant
Trimethylamine-containing compounds for diagnosis and prediction of...
- Patent number 10,983,100
- Issue date Apr 20, 2021
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- G01 - MEASURING TESTING
Information Patent Grant
Treating and preventing disease with TMA and TMAO lowering agents
- Patent number 10,933,072
- Issue date Mar 2, 2021
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for inhibiting conversion of choline to trimethylamine (TMA)
- Patent number 10,849,866
- Issue date Dec 1, 2020
- The Procter & Gamble Company
- Jose Carlos Garcia-Garcia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for inhibiting conversion of carnitine to trimethylamine (TMA)
- Patent number 10,786,479
- Issue date Sep 29, 2020
- The Procter & Gamble Company
- Stanley Leon Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for inhibiting conversion of choline to trimethylamine (TMA)
- Patent number 10,780,072
- Issue date Sep 22, 2020
- The Procter & Gamble Company
- Stanley Leon Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for inhibiting conversion of choline to trimethylamine (TMA)
- Patent number 10,751,301
- Issue date Aug 25, 2020
- The Procter & Gamble Company
- Jose Carlos Garcia-Garcia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for inhibiting conversion of choline to trimethylamine (TMA)
- Patent number 10,675,256
- Issue date Jun 9, 2020
- The Procter & Gamble Company
- Jose Carlos Garcia-Garcia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NMR quantification of TMAO
- Patent number 10,613,044
- Issue date Apr 7, 2020
- LipoScience, Inc.
- James D. Otvos
- G01 - MEASURING TESTING
Information Patent Grant
Trimethylamine compounds as risk predictors of cardiovascular disease
- Patent number 10,551,372
- Issue date Feb 4, 2020
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- G01 - MEASURING TESTING
Information Patent Grant
Trimethylamine-containing compounds for diagnosis and prediction of...
- Patent number 10,241,093
- Issue date Mar 26, 2019
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- G01 - MEASURING TESTING
Information Patent Grant
Compounds and methods for inhibiting production of trimethylamine
- Patent number 10,213,407
- Issue date Feb 26, 2019
- The Procter & Gamble Company
- Jose Carlos Garcia-Garcia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treating and preventing disease with TMA and TMAO lowering agents
- Patent number 10,117,879
- Issue date Nov 6, 2018
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment and prevention of cardiovascular disease and thrombosis
- Patent number 10,064,830
- Issue date Sep 4, 2018
- Stanley L. Hazen
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Grant
Treating and preventing disease with TMA and TMAO lowering agents
- Patent number 9,694,020
- Issue date Jul 4, 2017
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combined F2-isoprostane and myleoperoxidase detection, a risk indic...
- Patent number 9,612,242
- Issue date Apr 4, 2017
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Myeloperoxidase, a risk indicator for cardiovascular disease
- Patent number 9,581,597
- Issue date Feb 28, 2017
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Myeloperoxidase, a risk indicator for cardiovascular disease
- Patent number 9,575,065
- Issue date Feb 21, 2017
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NMR quantification of TMAO
- Patent number 9,541,620
- Issue date Jan 10, 2017
- LipoScience, Inc.
- James D. Otvos
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Oxidant resistant apolipoprotein A-1 and mimetic peptides
- Patent number 9,522,950
- Issue date Dec 20, 2016
- The Cleveland Clinic Foundation
- Jonathan D. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Myeloperoxidase, a risk indicator for cardiovascular disease
- Patent number 9,435,808
- Issue date Sep 6, 2016
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Trimethylamine compounds as risk predictors of cardiovascular disease
- Patent number 9,423,405
- Issue date Aug 23, 2016
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- G01 - MEASURING TESTING

Patents Applicationslast 30 patents

Information Patent Application
TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS
- Publication number 20240165131
- Publication date May 23, 2024
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- G01 - MEASURING TESTING
Information Patent Application
TREATING DISEASE AND PROMOTING WEIGHT LOSS BY INHIBITING THE TMA/FM...
- Publication number 20240139120
- Publication date May 2, 2024
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NMR Quantification of TMAO
- Publication number 20240125719
- Publication date Apr 18, 2024
- LipoScience, Inc.
- James D. Otvos
- G01 - MEASURING TESTING
Information Patent Application
DISEASE DETECTION AND TREATMENT BASED ON PHENYLACETYL GLUTAMINE LEVELS
- Publication number 20230091848
- Publication date Mar 23, 2023
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- G01 - MEASURING TESTING
Information Patent Application
DETECTION OF GLUCURONIDATED AND 3-BROMOTYROSINE
- Publication number 20220163540
- Publication date May 26, 2022
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- G01 - MEASURING TESTING
Information Patent Application
TRIMETHYLAMINE-CONTAINING COMPOUNDS FOR DIAGNOSIS AND PREDICTION OF...
- Publication number 20220065829
- Publication date Mar 3, 2022
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK
- Publication number 20210270855
- Publication date Sep 2, 2021
- The Cleveland Clinic Foundation
- Jonathan D. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APOA1 EXCHANGE RATE ASSAYS AS A DIAGNOSTIC FOR MAJOR ADVERSE CARDIO...
- Publication number 20210231691
- Publication date Jul 29, 2021
- The Cleveland Clinic Foundation
- Jonathan D. Smith
- G01 - MEASURING TESTING
Information Patent Application
TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS
- Publication number 20210186991
- Publication date Jun 24, 2021
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- G01 - MEASURING TESTING
Information Patent Application
DISEASE DETECTION AND TREATMENT BASED ON TRIMETHYL-LYSINE LEVELS
- Publication number 20210038550
- Publication date Feb 11, 2021
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- G01 - MEASURING TESTING
Information Patent Application
NMR Quantification of TMAO
- Publication number 20200355634
- Publication date Nov 12, 2020
- LipoScience, Inc.
- James D. Otvos
- G01 - MEASURING TESTING
Information Patent Application
PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK
- Publication number 20200209264
- Publication date Jul 2, 2020
- The Cleveland Clinic Foundation
- Jonathan D. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS
- Publication number 20200197417
- Publication date Jun 25, 2020
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIMETHYLAMINE COMPOUNDS AS RISK PREDICTORS OF CARDIOVASCULAR DISEASE
- Publication number 20200173979
- Publication date Jun 4, 2020
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- H01 - BASIC ELECTRIC ELEMENTS
Information Patent Application
METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)
- Publication number 20200138740
- Publication date May 7, 2020
- The Procter & Gamble Company
- Stanley Leon HAZEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)
- Publication number 20200138887
- Publication date May 7, 2020
- The Procter & Gamble Company
- Stanley Leon HAZEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING DISEASE AND PROMOTING WEIGHT LOSS BY INHIBITING THE TMA/FM...
- Publication number 20200121615
- Publication date Apr 23, 2020
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DETECTION OF GLUCURONIDATED AND 3-BROMOTYROSINE
- Publication number 20190257840
- Publication date Aug 22, 2019
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- G01 - MEASURING TESTING
Information Patent Application
TRIMETHYLAMINE-CONTAINING COMPOUNDS FOR DIAGNOSIS AND PREDICTION OF...
- Publication number 20190234917
- Publication date Aug 1, 2019
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)
- Publication number 20190099384
- Publication date Apr 4, 2019
- The Procter & Gamble Company
- Jose Carlos GARCIA-GARCIA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)
- Publication number 20190099390
- Publication date Apr 4, 2019
- The Procter & Gamble Company
- Jose Carlos GARCIA-GARCIA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)
- Publication number 20190099389
- Publication date Apr 4, 2019
- The Procter & Gamble Company
- Jose Carlos GARCIA-GARCIA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS
- Publication number 20190038642
- Publication date Feb 7, 2019
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- G01 - MEASURING TESTING
Information Patent Application
METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)
- Publication number 20180000754
- Publication date Jan 4, 2018
- The Procter & Gamble Company
- Stanley Leon Hazen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK
- Publication number 20170336425
- Publication date Nov 23, 2017
- The Cleveland Clinic Foundation
- Jonathan D. Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS
- Publication number 20170266208
- Publication date Sep 21, 2017
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE AND THROMBOSIS
- Publication number 20170258740
- Publication date Sep 14, 2017
- The Cleveland Clinic Foundation
- Stanley L. Hazen
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
NMR QUANTIFICATION OF TMAO
- Publication number 20170184521
- Publication date Jun 29, 2017
- LipoScience, Inc.
- James D. Otvos
- G01 - MEASURING TESTING
Information Patent Application
COMPOUNDS AND METHODS FOR INHIBITING PRODUCTION OF TRIMETHYLAMINE
- Publication number 20170152222
- Publication date Jun 1, 2017
- The Procter & Gamble Company
- Jose Carlos GARCIA-GARCIA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)
- Publication number 20170151208
- Publication date Jun 1, 2017
- The Procter & Gamble Company
- Stanley Leon HAZEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Stanley Leon HAZEN

Person

Patents Grantslast 30 patents

Detection of glucuronidated and 3-bromotyrosine

Trimethylamine compounds as risk predictors of cardiovascular disease

Treating and preventing disease with TMA and TMAO lowering agents

TMA-formation inhibitor treatment for elevated TMA-containing compo...

NMR quantification of TMAO

Treating disease and promoting weight loss by inhibiting the TMA/FM...

Methods for inhibiting conversion of choline to trimethylamine (TMA)

Methods for inhibiting conversion of choline to trimethylamine (TMA)

Detection of glucuronidated and 3-bromotyrosine

Trimethylamine-containing compounds for diagnosis and prediction of...

Treating and preventing disease with TMA and TMAO lowering agents

Methods for inhibiting conversion of choline to trimethylamine (TMA)

Methods for inhibiting conversion of carnitine to trimethylamine (TMA)

Methods for inhibiting conversion of choline to trimethylamine (TMA)

Methods for inhibiting conversion of choline to trimethylamine (TMA)

Methods for inhibiting conversion of choline to trimethylamine (TMA)

NMR quantification of TMAO

Trimethylamine compounds as risk predictors of cardiovascular disease

Trimethylamine-containing compounds for diagnosis and prediction of...

Compounds and methods for inhibiting production of trimethylamine

Treating and preventing disease with TMA and TMAO lowering agents

Treatment and prevention of cardiovascular disease and thrombosis

Treating and preventing disease with TMA and TMAO lowering agents

Combined F2-isoprostane and myleoperoxidase detection, a risk indic...

Myeloperoxidase, a risk indicator for cardiovascular disease

Myeloperoxidase, a risk indicator for cardiovascular disease

NMR quantification of TMAO

Oxidant resistant apolipoprotein A-1 and mimetic peptides

Myeloperoxidase, a risk indicator for cardiovascular disease

Trimethylamine compounds as risk predictors of cardiovascular disease

Patents Applicationslast 30 patents

TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS

TREATING DISEASE AND PROMOTING WEIGHT LOSS BY INHIBITING THE TMA/FM...

NMR Quantification of TMAO

DISEASE DETECTION AND TREATMENT BASED ON PHENYLACETYL GLUTAMINE LEVELS

DETECTION OF GLUCURONIDATED AND 3-BROMOTYROSINE

TRIMETHYLAMINE-CONTAINING COMPOUNDS FOR DIAGNOSIS AND PREDICTION OF...

PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK

APOA1 EXCHANGE RATE ASSAYS AS A DIAGNOSTIC FOR MAJOR ADVERSE CARDIO...

TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS

DISEASE DETECTION AND TREATMENT BASED ON TRIMETHYL-LYSINE LEVELS

NMR Quantification of TMAO

PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK

TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS

TRIMETHYLAMINE COMPOUNDS AS RISK PREDICTORS OF CARDIOVASCULAR DISEASE

METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)

METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)

TREATING DISEASE AND PROMOTING WEIGHT LOSS BY INHIBITING THE TMA/FM...

DETECTION OF GLUCURONIDATED AND 3-BROMOTYROSINE

TRIMETHYLAMINE-CONTAINING COMPOUNDS FOR DIAGNOSIS AND PREDICTION OF...

METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)

METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)

METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)

TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS

METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)

PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK

TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS

TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE AND THROMBOSIS

NMR QUANTIFICATION OF TMAO

COMPOUNDS AND METHODS FOR INHIBITING PRODUCTION OF TRIMETHYLAMINE

METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA)